508 related articles for article (PubMed ID: 30885458)
21. Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G; Jereczek-Fossa BA; Vischioni B; Ciardo D; Giandini T; Hasegawa A; Cattani F; Carrara M; Ciocca M; Bedini N; Villa S; Morlino S; Russo S; Zerini D; Colangione SP; Panaino CMV; Fodor C; Santoro L; Pignoli E; Valvo F; Valdagni R; De Cobelli O; Orecchia R
Tumori; 2017 May; 103(3):314-318. PubMed ID: 28009421
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of colon cancer after external radiation therapy for prostate cancer.
Rapiti E; Fioretta G; Verkooijen HM; Zanetti R; Schmidlin F; Shubert H; Merglen A; Miralbell R; Bouchardy C
Int J Cancer; 2008 Sep; 123(5):1141-5. PubMed ID: 18546265
[TBL] [Abstract][Full Text] [Related]
23. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments.
Bolch CA; Chu H; Jarosek S; Cole SR; Elliott S; Virnig B
BMC Med Res Methodol; 2017 Jul; 17(1):93. PubMed ID: 28693428
[TBL] [Abstract][Full Text] [Related]
24. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
[TBL] [Abstract][Full Text] [Related]
25. Incidence of second tumours in high risk prostate cancer patients according to the primary treatment applied.
Caño-Velasco J; Herranz-Amo F; Barbas-Bernardos G; Polanco-Pujol L; Lledó-García E; Hernández-Fernández C
Actas Urol Esp (Engl Ed); 2019; 43(1):18-25. PubMed ID: 30119969
[TBL] [Abstract][Full Text] [Related]
26. Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.
Vuolukka K; Auvinen P; Palmgren JE; Aaltomaa S; Kataja V
BMC Cancer; 2020 May; 20(1):453. PubMed ID: 32434560
[TBL] [Abstract][Full Text] [Related]
27. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Fizazi K; Faivre L; Lesaunier F; Delva R; Gravis G; Rolland F; Priou F; Ferrero JM; Houede N; Mourey L; Theodore C; Krakowski I; Berdah JF; Baciuchka M; Laguerre B; Fléchon A; Ravaud A; Cojean-Zelek I; Oudard S; Labourey JL; Chinet-Charrot P; Legouffe E; Lagrange JL; Linassier C; Deplanque G; Beuzeboc P; Davin JL; Martin AL; Habibian M; Laplanche A; Culine S
Lancet Oncol; 2015 Jul; 16(7):787-94. PubMed ID: 26028518
[TBL] [Abstract][Full Text] [Related]
28. Secondary cancers after carbon-ion radiotherapy and photon beam radiotherapy for uterine cervical cancer: A comparative study.
Nitta Y; Murata H; Okonogi N; Murata K; Wakatsuki M; Karasawa K; Kato S; Yamada S; Nakano T; Tsuji H
Cancer Med; 2022 Jun; 11(12):2445-2454. PubMed ID: 35318825
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.
Zhao SG; Chang SL; Spratt DE; Erho N; Yu M; Ashab HA; Alshalalfa M; Speers C; Tomlins SA; Davicioni E; Dicker AP; Carroll PR; Cooperberg MR; Freedland SJ; Karnes RJ; Ross AE; Schaeffer EM; Den RB; Nguyen PL; Feng FY
Lancet Oncol; 2016 Nov; 17(11):1612-1620. PubMed ID: 27743920
[TBL] [Abstract][Full Text] [Related]
30. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR
JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865
[TBL] [Abstract][Full Text] [Related]
31. Risk of second primary cancer in patients treated with radiotherapy for rectal cancer.
Martling A; Smedby KE; Birgisson H; Olsson H; Granath F; Ekbom A; Glimelius B
Br J Surg; 2017 Feb; 104(3):278-287. PubMed ID: 27802358
[TBL] [Abstract][Full Text] [Related]
32. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
33. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
Singh AK; Mashtare TL; McCloskey SA; Seixas-Mikelus SA; Kim HL; May KS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1086-94. PubMed ID: 20350797
[TBL] [Abstract][Full Text] [Related]
34. A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS).
Nomiya T; Tsuji H; Kawamura H; Ohno T; Toyama S; Shioyama Y; Nakayama Y; Nemoto K; Tsujii H; Kamada T
Radiother Oncol; 2016 Nov; 121(2):288-293. PubMed ID: 27836119
[TBL] [Abstract][Full Text] [Related]
35. Impact of initial local therapy on survival in men later receiving chemotherapy for prostate cancer: a population-based, propensity-weighted multivariable analysis.
Zabell JR; Adejoro O; Jarosek SL; Elliott SP; Konety BR
World J Urol; 2016 Oct; 34(10):1397-403. PubMed ID: 26914817
[TBL] [Abstract][Full Text] [Related]
36. Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality.
Tilki D; Chen MH; Wu J; Huland H; Graefen M; Braccioforte M; Moran BJ; D'Amico AV
JAMA Oncol; 2019 Feb; 5(2):213-220. PubMed ID: 30452521
[TBL] [Abstract][Full Text] [Related]
37. Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.
Song C; Kang HC; Kim JS; Eom KY; Kim IA; Chung JB; Hong SK; Byun SS; Lee SE
Strahlenther Onkol; 2015 Oct; 191(10):801-9. PubMed ID: 26159555
[TBL] [Abstract][Full Text] [Related]
38. Complications after radical prostatectomy or radiotherapy for prostate cancer: results of a population-based, propensity score-matched analysis.
Wallis CJ; Herschorn S; Saskin R; Su J; Klotz LH; Chang M; Kulkarni GS; Lee Y; Kodama RT; Narod SA; Nam RK
Urology; 2015 Mar; 85(3):621-7. PubMed ID: 25733275
[TBL] [Abstract][Full Text] [Related]
39. Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702".
Kawamura H; Kubo N; Sato H; Mizukami T; Katoh H; Ishikawa H; Ohno T; Matsui H; Ito K; Suzuki K; Nakano T;
BMC Cancer; 2020 Jan; 20(1):75. PubMed ID: 32000716
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]